Annovis Bio Inc.
4.83
0.16 (3.43%)
At close: Jan 15, 2025, 2:41 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -56.20M -25.33M -14.49M -5.46M -990.98K -713.87K -682.35K
Depreciation & Amortization n/a n/a n/a 129.00K 1.19M n/a n/a
Stock-Based Compensation 4.63M 9.15M 4.70M 1.86M 8.48K 82.73K 48.49K
Other Working Capital 2.44M -4.41M 311.13K 294.95K -547.57K 75.22K 34.55K
Other Non-Cash Items 9.17M 5.88M 4.35M 27.02K 84.43K 85.41K 11.58K
Deferred Income Tax n/a n/a n/a -129.00K -1.19M n/a n/a
Change in Working Capital 2.44M -1.14M 657.35K -400.71K 421.53K 72.53K 96.37K
Operating Cash Flow -39.97M -17.31M -9.13M -3.97M -476.54K -558.61K -537.48K
Capital Expenditures n/a n/a n/a n/a n/a n/a n/a
Acquisitions n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow n/a n/a n/a n/a n/a n/a n/a
Debt Repayment n/a n/a n/a n/a 530.00K n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 458.38K 4.61K 95.10K 9.22K -86.91K 490.10K 656.50K
Financial Cash Flow 17.34M 4.61K 46.74M 12.04M 443.09K 246.45K 332.50K
Net Cash Flow -22.62M -17.31M 37.61M 8.07M -33.45K -312.16K -204.99K
Free Cash Flow -39.97M -17.31M -9.13M -3.97M -476.54K -558.61K -537.48K